Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain
- PMID: 9520235
- DOI: 10.1016/s0304-3959(97)00172-3
Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain
Abstract
The treatment of neuropathic pain with opioid analgesics is a matter of controversy among clinicians and clinician scientists. Although neuropathic pain is usually believed to be only slightly responsive to opioids, several studies show that satisfactory analgesia can be obtained if adequate doses are administered. In the present study, we tested the effectiveness of buprenorphine in 21 patients soon after thoracic surgery (nociceptive postoperative pain) and 1 month after surgery in the same 21 patients who developed postthoracotomy neuropathic pain with a burning, electrical and shooting quality. According to a double-blind randomized study, the analgesic dose (AD) of buprenorphine needed to reduce the long-term neuropathic pain by 50% (AD50) was calculated and compared to the AD50 in the immediate postoperative period. We found that long-term neuropathic pain could be adequately reduced by buprenorphine. However, the AD50 in neuropathic pain was significantly higher relative to the AD50 in the short-term postoperative pain, indicating a lower responsiveness of neuropathic pain to opioids. We also found a strict relationship between the short-term and long-term AD50, characterized by a saturating effect. In fact, if the AD50 soon after surgery was low, the AD50 increase in the long-term neuropathic pain was threefold. By contrast, if the AD50 soon after surgery was high, the AD50 in neuropathic pain was only slightly increased. This suggests that, though neuropathic pain is indeed less sensitive to opioids, in some neuropathic patients a large amount of opioid resistance is already present in other painful conditions.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.Clin Ther. 2009 Mar;31(3):527-41. doi: 10.1016/j.clinthera.2009.03.018. Clin Ther. 2009. PMID: 19393843 Clinical Trial.
-
Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies.Anesth Analg. 2005 Mar;100(3):781-785. doi: 10.1213/01.ANE.0000145066.06538.20. Anesth Analg. 2005. PMID: 15728068
-
Efficacy of buprenorphine added to 2% lignocaine plus adrenaline 1:80,000 in providing postoperative analgesia after lower third molar surgery.Int J Oral Maxillofac Surg. 2016 Dec;45(12):1644-1651. doi: 10.1016/j.ijom.2016.08.003. Epub 2016 Aug 28. Int J Oral Maxillofac Surg. 2016. PMID: 27576596 Clinical Trial.
-
Buprenorphine--a review of its role in neuropathic pain.J Opioid Manag. 2007 Jul-Aug;3(4):195-206. doi: 10.5055/jom.2007.0005. J Opioid Manag. 2007. PMID: 17957979 Review.
Cited by
-
Effect of recombinant adenovirus coding for endomorphin-2 on neuropathic pain in rats.Int J Clin Exp Pathol. 2012;5(9):914-23. Epub 2012 Oct 20. Int J Clin Exp Pathol. 2012. PMID: 23119108 Free PMC article.
-
Perioperative systemic magnesium sulphate to minimize acute and chronic post-thoracotomy pain: a prospective observational study.J Thorac Dis. 2019 Feb;11(2):418-426. doi: 10.21037/jtd.2019.01.50. J Thorac Dis. 2019. PMID: 30962985 Free PMC article.
-
Pretreatment with intrathecal amitriptyline potentiates anti-hyperalgesic effects of post-injury intra-peritoneal amitriptyline following spinal nerve ligation.BMC Neurol. 2012 Jun 21;12:44. doi: 10.1186/1471-2377-12-44. BMC Neurol. 2012. PMID: 22720761 Free PMC article.
-
Opioid resistance in chronic daily headache: a synthesis of ideas from the bench and bedside.Curr Pain Headache Rep. 2003 Feb;7(1):67-75. doi: 10.1007/s11916-003-0013-5. Curr Pain Headache Rep. 2003. PMID: 12525274 Review.
-
Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury.Eur J Pain. 2011 Aug;15(7):669-75. doi: 10.1016/j.ejpain.2010.11.018. Epub 2011 Feb 9. Eur J Pain. 2011. PMID: 21310637 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources